tiprankstipranks
Graphite Bio (GRPH)
NASDAQ:GRPH
US Market

Graphite Bio (GRPH) Stock News & Sentiment

107 Followers
Graphite Bio’s Strategic Merger and Rebranding to LENZ Therapeutics
PremiumCompany Announcements
Graphite Bio’s Strategic Merger and Rebranding to LENZ Therapeutics
1M ago
Graphite Bio trading halted, news pending
PremiumThe Fly
Graphite Bio trading halted, news pending
1M ago
Graphite Bio Approves Merger, Name Change, and Stock Split
PremiumCompany Announcements
Graphite Bio Approves Merger, Name Change, and Stock Split
1M ago
Is GRPH a Buy, Before Earnings?
PremiumPre-Earnings
Is GRPH a Buy, Before Earnings?
1M ago
Graphite Bio trading halted, news pending
PremiumThe Fly
Graphite Bio trading halted, news pending
1M ago
Graphite Bio Announces Special Dividend Amid Lenz Merger
PremiumCompany Announcements
Graphite Bio Announces Special Dividend Amid Lenz Merger
2M ago
Graphite Bio declares special dividend estimated at $1.03 per share
PremiumThe Fly
Graphite Bio declares special dividend estimated at $1.03 per share
2M ago
More GRPH News >

GRPH News on the Web

News Score - Last 7 Days

Neutral
GRPH
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.75 articles
News Sentiment
This Week50%
Sector Average66%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GRPH’s Media Buzz Sentiment?
3 articles about GRPH were published this week. In an average week, 2.75 articles are published.
    What is GRPH’s weekly average amount of articles?
    In an average week, 2.75 articles about GRPH are published.
      What is GRPH’s News Sentiment?
      50% of articles about GRPH were positive this week, compared to its sector average of 66%.
        Healthcare Stocks that are Trending in the News
        SERASera Prognostics
        FUSNFusion Pharmaceuticals
        TELATELA Bio
        TNYATenaya Therapeutics
        CNTXContext Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis